Cancer Care Quality Measurement & Reporting

Given the range of settings in which people receive cancer care, the large number of people afflicted with cancer, and the lack of robust data on the quality of care, making widespread improvements to cancer care is a challenge. Improving the quality of care will require, at a minimum, a system that can measure and track changes in the quality of care, can be used at many different kinds of institutions, and captures and reports data in real time. The system must also be reliable enough to be potentially used as a basis for rewards (such as a pay-for-performance system), and to enhance patient choice. 

Members of the Center are engaged in research and policy development related to measuring different aspects of cancer care quality. Their work seeks to uncover variations in practice that could explain differences in outcomes. The goal is for measurement to lead to the identification of modifiable factors that could improve the quality of care and ultimately improve outcomes for patients with cancer.

Recently, members of the Center collaborated with Mathematica and other partners to successfully develop an “Admissions and Emergency Department (ED) Visits for Patients Receiving Outpatient Chemotherapy” measure with the goal of assessing the current provision of care and eventually reducing preventable ED visits and hospital admissions.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Lipitz-Snyderman A, Pfister D, Classen D, Atoria CL, Killen A, Epstein AS, Anderson C, Fortier E, Weingart SN. Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum. Cancer. 2017. doi: 10.1002/cncr.30916.

Lipitz-Snyderman A, Sima CS, Atoria CL, Elkin EB, Anderson C, Blinder V, Tsai CJ, Panageas KS, Bach PB. Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer. JAMA Intern Med. 2016 Oct 1;176(10):1541-1548. PMCID: PMC5363077.

Lipitz-Snyderman A, Elkin EB, Atoria CL, Sima CS, Epstein AS, Blinder V, Sepkowitz KA, Bach PB. Provider Differences in Use of Implanted Ports in Older Adults With Cancer. Med Care. 2015 Jul;53(7):646-52. PMCID: PMC4962697.

Daly B, Olopade OI, Hou N, Yao K, Winchester DJ, Huo D. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. JAMA Oncol. 2017 Jul 1;3(7):928-935. doi: 10.1001/jamaoncol.2016.6380.

Stover AM, Basch EM. Using patient-reported outcome measures as quality indicators in routine cancer care. Cancer. 2016 Feb 1;122(3):355-7. doi: 10.1002/cncr.29768. Epub 2015 Nov 30.

Schleicher SM, Wood NM, Lee S, Feeley TW. How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved? Oncology (Williston Park). 2016 May;30(5):468-74. Review.

Mailankody S. Affordable Care Act, Health Insurance Coverage, and Cancer Outcomes. J Clin Oncol. 2017 Oct 16:JCO2017754259. doi: 10.1200/JCO.2017.75.4259. [Epub ahead of print]